Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.40
-0.60 (-2.00%)
Apr 29, 2026, 1:54 PM CST

Genomics BioSci & Tech. Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
2,1551,8621,3911,5071,2571,126
Upgrade
Market Cap Growth
67.13%33.85%-7.69%19.84%11.67%0.78%
Upgrade
Enterprise Value
2,6822,3851,6221,4161,2331,074
Upgrade
Last Close Price
29.7525.7019.2020.8019.3518.37
Upgrade
PE Ratio
----17.5660.09
Upgrade
PS Ratio
3.042.632.693.803.002.89
Upgrade
PB Ratio
3.703.202.171.971.591.66
Upgrade
P/TBV Ratio
4.283.702.561.971.601.66
Upgrade
EV/Sales Ratio
3.793.373.133.572.942.75
Upgrade
EV/EBITDA Ratio
-----1319.50
Upgrade
Debt / Equity Ratio
1.081.080.790.370.290.13
Upgrade
Debt / EBITDA Ratio
-----18.95
Upgrade
Net Debt / Equity Ratio
0.780.780.420.04-0.11-0.03
Upgrade
Net Debt / EBITDA Ratio
-21.97-21.97-3.15-0.6216.29-25.75
Upgrade
Net Debt / FCF Ratio
-2.84-2.84-0.88-0.120.770.17
Upgrade
Asset Turnover
0.510.510.420.350.430.39
Upgrade
Inventory Turnover
2.262.262.924.757.4712.45
Upgrade
Quick Ratio
0.670.670.982.532.472.02
Upgrade
Current Ratio
1.201.201.613.232.952.66
Upgrade
Return on Equity (ROE)
-11.06%-11.06%-33.47%-21.62%9.75%1.52%
Upgrade
Return on Assets (ROA)
-3.77%-3.77%-7.03%-4.54%-2.12%-1.78%
Upgrade
Return on Invested Capital (ROIC)
-8.03%-8.64%-16.44%-10.94%-4.89%-5.17%
Upgrade
Return on Capital Employed (ROCE)
-9.40%-9.40%-14.40%-8.30%-3.50%-3.80%
Upgrade
Earnings Yield
-1.83%-2.12%-16.04%-11.15%5.69%1.66%
Upgrade
FCF Yield
-7.44%-8.61%-21.95%-16.34%-9.16%-10.78%
Upgrade
Dividend Yield
----0.51%-
Upgrade
Payout Ratio
----0.00%0.19%
Upgrade
Buyback Yield / Dilution
---1.89%-11.87%-5.12%-0.23%
Upgrade
Total Shareholder Return
---1.89%-11.87%-4.62%-0.23%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.